Akira Taguchi

Hiroshima, 7348551, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.

Journal: Journal of neuro-oncology

Published: February 15, 2026

Rasmussen encephalitis without atrophy and increased 11C-methionine PET uptake mimicking glioma: A case report.

Rasmussen encephalitis without atrophy and increased 11C-methionine PET uptake mimicking glioma: A case report.

Journal: The neuroradiology journal

Published: December 20, 2025

Cortical Diffusion-Enhancement Mismatch Sign: A Specific Imaging Biomarker for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma.

Cortical Diffusion-Enhancement Mismatch Sign: A Specific Imaging Biomarker for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma.

Journal: Neurosurgery

Published: October 24, 2025

Automatic acromegaly detection using deep learning on hand images: a multicenter observational study.

Automatic acromegaly detection using deep learning on hand images: a multicenter observational study.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 06, 2025

Possible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing.

Possible involvement of genome-wide near-haploidy and MEN1 mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing.

Journal: Neuro-oncology advances

Published: September 24, 2025

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.

Journal: Japanese journal of clinical oncology

Published: July 16, 2025

Differences in clinical course between pituitary apoplexy and non-apoplexy patients with nonfunctioning pituitary neuroendocrine tumors.

Differences in clinical course between pituitary apoplexy and non-apoplexy patients with nonfunctioning pituitary neuroendocrine tumors.

Journal: Neurosurgical review

Published: June 26, 2025

Multinodular and vacuolating posterior fossa lesions of unknown significance: a long-term observational study and literature review.

Multinodular and vacuolating posterior fossa lesions of unknown significance: a long-term observational study and literature review.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: November 09, 2024

Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.

Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant.

Journal: Journal of neuro-oncology

Published: October 31, 2024

Management policy for postoperative acromegaly patients with normal IGF-1 and high GH levels on oral glucose tests.

Management policy for postoperative acromegaly patients with normal IGF-1 and high GH levels on oral glucose tests.

Journal: Pituitary

Published: October 09, 2024

Preventing Post-incisional Dural Shrink in Craniotomy: Introducing the "Roll-up Technique".

Preventing Post-incisional Dural Shrink in Craniotomy: Introducing the "Roll-up Technique".

Journal: Neurologia medico-chirurgica

Published: June 05, 2024

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.

Journal: Journal of neuro-oncology

Published: May 06, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026